Arrowhead Pharmaceuticals, Inc. (ARWR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 84.44M | 13.48M | 20.49M | -154.72M | 460.05M | -146.27M | -137.22M | -115.42M | -92.38M | -117.84M | -25.26M | -20.78M |
| Operating CF Margin % | 114.52% | 5.11% | 7.99% | -557.21% | 84.77% | -5850.88% | - | - | - | -3318.5% | -156.91% | -131.29% |
| Operating CF Growth % | -81.65% | 109.22% | 114.93% | -34.05% | 598.02% | -24.13% | -443.28% | -455.51% | -191.68% | -56.05% | 63.22% | 69.81% |
| Net Income | -132.73M | 28.24M | 16.12M | -178.65M | 367.86M | -175.22M | -173.34M | -173.98M | -127M | -135.38M | -111.02M | -104.13M |
| Depreciation & Amortization | 6.37M | 6.39M | 6.39M | 6.22M | 6.08M | 5.24M | 5.03M | 4.78M | 4.53M | 4.26M | 3.86M | 3.28M |
| Stock-Based Compensation | 0 | 19.37M | 19.09M | 13.04M | 16.03M | 15.21M | 19.47M | 17.05M | 17.75M | 19.69M | 18.18M | 19.95M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 22.65M | 21.27M | 17.26M | 22.63M | 24.55M | 15.94M | 3.68M | 12.08M | 8.98M | 4.45M | 4.28M | 4.21M |
| Working Capital Changes | 188.15M | -61.79M | -38.36M | -17.96M | 45.52M | -7.44M | 7.95M | 24.64M | 3.37M | -10.87M | 59.44M | 55.91M |
| Change in Receivables | 203.19M | -212.05M | -47.13M | -7.48M | 135K | -2.5M | 0 | 0 | 0 | 0 | 1.25M | 68.19M |
| Change in Inventory | 0 | -451K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -2.19M | 15.26M | -15.38M | 23.38M | -4.79M | 3.07M | -8.32M | 11.19M | 4.06M | -12.46M | 28M | -1.69M |
| Cash from Investing | -894.28M | -23.74M | 72.62M | 141.39M | -420.21M | 76.91M | -222.92M | 6.95M | -268.94M | 64.84M | 30.51M | -9.9M |
| Capital Expenditures | -2.56M | -2.15M | -7.49M | -2.36M | -5.3M | -7.52M | -24.29M | -14.45M | -34.08M | -68.66M | -63.91M | -46.6M |
| CapEx % of Revenue | 3.48% | 0.81% | 2.92% | 8.51% | 0.98% | 300.64% | - | - | - | 1933.43% | 397.01% | 294.5% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 795.72M | -14.75M | 3.67M | -42.68M | 92.38M | 20.63M | 389.09M | 50.39M | 430.78M | 267K | 152K | 1.14M |
| Debt Issued (Net) | 663.46M | -66.68M | 10.26M | -50M | -151.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 221.65M | 51.93M | 507K | 223K | 244.01M | 25.63M | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -89.39M | 0 | -7.1M | 7.1M | 0 | -5M | 389.09M | 50.39M | 430.78M | 267K | 152K | 1.14M |
| Net Change in Cash | -13.13M | -24.91M | 96.75M | -55.92M | 131.82M | -48.8M | 33.29M | -58.3M | 69.49M | -52.68M | 5.56M | -29.63M |
| Free Cash Flow | 81.88M | 11.33M | 13M | -157.08M | 454.76M | -153.79M | -161.5M | -129.87M | -126.45M | -186.5M | -89.16M | -67.38M |
| FCF Margin % | 111.04% | 4.29% | 5.07% | -565.72% | 83.79% | -6151.52% | - | - | - | -5251.93% | -553.92% | -425.79% |
| FCF Growth % | -82% | 107.37% | 108.05% | -20.96% | 459.63% | 17.54% | -81.13% | -92.73% | -114.38% | -62.98% | 12.05% | 14% |
| FCF per Share | 0.57 | 0.08 | 0.10 | -1.13 | 3.38 | -1.23 | -1.32 | -1.05 | -1.03 | -1.74 | -0.83 | -0.63 |
| FCF Conversion (FCF/Net Income) | -0.64x | 0.44x | -0.86x | 0.88x | 1.24x | 0.85x | 0.80x | 0.68x | 0.74x | 0.89x | 0.23x | 0.20x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 9.91M | 0 | 0 | 70K | 11K | 682K | 48K | 2.02M | 999K | 0 | 0 |